具有聚集态荧光增强性质的新型Tr?ger’s Base衍生物的合成与表征

Tr?ger’s bases(TB)具有特殊的刚性、立体Λ-型扭转构型,理论上,在分子堆积时其空间位阻作用不利于形成易引起"固态荧光淬灭"π-π密堆积,可以有效改善有机发光材料中常见的由π-π密堆积引起的固态荧光淬灭现象.选择Λ-型TB骨架作为分子的基本框架,首先以溴代Λ-型TB为原料合成了醛基取代的TB,再通过醛基-TB与取代苯乙腈类化合物经过简单的Knoevenagel缩合反应首次高效地合成了4个具有聚集态荧光增强特性的TB-氰基取代苯乙烯衍生物1a、2a、3a和4a,我们又通过钯催化的Heck偶联反应成功地将2-乙烯基噻吩引入到Λ-型TB中,合成了结构对称的D-π-C-π-D型TB衍生物5a,这些化合物均具有较大的Stokes位移.所有产物均通过1H NMR,13C NMR和HRMS等进行表征,并详细地对这些化合物的光电物理性质等进行了深入的研究,并重点探索验证了这些化合物的聚集诱导发光现象,它们在掺水聚集过程中均表现出明显的聚集荧光增强的性质,表明我们所合成的这些化合物均具有良好的聚集诱导发光性能(AIE).通过测试化合物1a、2a和5a在不同溶剂中的紫外吸收光谱和荧光光谱,表明化合物2a具有一定的溶剂效应,且这3个化合物的荧光发射峰位置都随着溶剂极性不同而发生变化,说明这些化合物存在着一定的ICT跃迁效应.通过对这些化合物的初步探究,希望这类新型固态发光TB衍生物能够在电致发光材料等领域具有潜在的应用价值.     

荧光1,2,4-噻二唑-3,5-二酮衍生物的合成及其对精子的标记作用

合成了3个含有荧光基团的1,2,4-噻二唑-3,5-二酮衍生物,其结构经¹H NMR,¹³C NMR, HR-MS(ESI)表征,并考察了这些衍生物对精子的制动活性和荧光标记作用。结果表明：与先导化合物Tideglusib相比,目标化合物均保持了较强的杀精活性,且在紫外光激发下,具有相似的荧光标记模式。     

新型偶氮化合物的合成及其光学性质

以咔唑和苯酚为原料,经重氮和偶合反应合成了一种新型偶氮化合物--N-对(4-羟基苯偶氮基)苯基-3,6-二(叔丁基)咔唑(4),其结构经1H NMR和13C NMR表征.4的 UV和固体荧光光谱研究结果表明,4具有较好的光学活性.     

新的N-苯并噻唑基香豆素酰胺类化合物的合成及光谱特性

用具有光学活性和生物学活性的2类化合物(取代)香豆素-3-甲酰氯和2-氨基苯并噻唑作用合成了4种新的兼具香豆素骨架和苯并噻唑基的化合物(3a-3d),用HRMS,IR和1H NMR对化合物结构进行了表征,确定了化合物的结构,并对其紫外吸收光谱和荧光光谱与分子结构的关系进行了讨论.研究发现:在紫外光谱中,新化合物(3a-3d)和2种原料化合物相比,因共轭链的增长而使其最大吸收波长(λmax)红移;4种化合物表现出比原料化合物较强的荧光性能,其中3c的荧光强度最大.文中给出了稀溶液中紫外光谱和荧光光谱相关的一些信息.     

新型咔唑羧酸类衍生物的合成、表征及光学性质研究

以咔唑为原料,合成了一种新型的咔唑类衍生物-9-异辛基-3, 6-咔唑二丙烯酸,其结构经1H NMR, IR和MS表征。运用UV、单光子液体荧光和固体荧光研究了中间体和目标产物的线性光学性质。结果表明：该化合物有望成为具有应用价值的发光材料。     

1,3-二苯基-5-吡唑啉酮三种异构体的结构及其发光性能

本文以1,3-二苯基-5-吡唑啉酮(DPP)为研究对象,采用不同溶剂对其进行重结晶,得到了3种不同颜色和不同构型的异构体。通过XRD粉末衍射、IR、1H NMR等确定了3种异构体的组成和结构,通过荧光光谱研究了它们的发光行为。结果表明这类化合物具有聚集诱导发光性能和光异构化性能,而且溶剂对产物的构型及发光性能均有明显的影响。此外,将该化合物与无规聚苯乙烯复合制备的薄膜也具有很好的荧光性能,在防伪领域具有潜在的应用。     

4-AHBA为核的聚芳醚树枝状化合物的合成及其光学性能

合成了三个新的以2-(4-氨基-2-羟基苯基)苯并噻唑(4-AHBA)为核的聚芳醚树枝状化合物(1a～1c),其结构由1H NMR,13C NMR,IR,MS和元素分析表征.研究了1和4-AHBA在氯仿中的紫外吸收光谱和荧光发射光谱,结果表明,1与4-AHBA相比,紫外吸收强度大大提高,且最大吸收波长从349 nm红移...     

含苯并咪唑单元共轭结构化合物及其有机发光二极管(OLED)器件发光性能研究

设计合成了系列含苯并咪唑单元的共轭结构化合物,用~1H NMR,~(13)C NMR,MS和元素分析进行了结构表征,测试了它们的紫外吸收波长(λ_a)、荧光发射波长(λ_e)、荧光量子产率(Φ)和荧光寿命(τ),讨论了分子结构与其光谱特性之间的关系.结果表明这类化合物能够表现出较强的发光性能,Φ值最高者达到0.91.以1,4-二-[2-(1-苄基苯并咪唑基)]苯(5b)制作出的有机发光二极管(OLED),其发光主峰在448 nm,在电压23.8 V(875 mA·cm~(-2))时最大亮度到达6790 cd·m~(-2),最大电流功效1.17 cd·A~(-1),最大功率效率0.96 lm·W~(-1),最大外部量子效率0.92%,这些数据表明该类化合物作为OLED材料具有较大的潜在应用价值.     

哌嗪取代查尔酮衍生物的合成及其细胞毒活性

以4-甲氧基苯甲醛与2-溴-4’-氟苯乙酮为原料,经羟醛缩合脱水、取代反应生成4-甲氧基-4’-(1-哌嗪基)查尔酮(2),再通过酰化反应合成了10个新型含哌嗪的查尔酮衍生物,其结构经~1H NMR、~(13)C NMR及HRMS确证。采用MTT法初步测试了目标化合物的体外细胞毒活性,结果表明,化合物3e和4d对肿瘤细胞株Hela和A549均表现出较好的细胞毒活性,可做进一步研究。     

PDE-4抑制剂的设计、合成及生物活性研究

依据药效团原理,对已报道的磷酸二酯酶(PDE-4)抑制剂Crisaborole进行结构修饰和改造,设计并合成了7个全新的小分子化合物,其结构经~1H NMR、~(13)C NMR和HRMS确证.研究其对磷酸二酯酶-4A(PDE-4A)的抑制活性、抑制炎症因子TNF-α释放效果以及抗炎活性.结果表明,所设计的7个化合物均表现出良好生物活性,其中一个化合物活性明显优于阳性对照药.     

Synthesis of Fluorescent 2,6‐Dicyano‐3,5‐Disubstituted Anilines Using Cellulose Sulfuric Acid in Aqueous Media

The synthesis of some fluorescent 2,6‐dicyano‐3,5‐disubstituted anilines using cellulose sulfuric acid (Cellulose‐SA) as an environmentally benign catalyst in H₂O is described. The one‐pot reaction of 1,3‐diketone and three equiv. of malononitrile was carried out in the presence of one equiv. of a secondary amine, Cellulose‐SA as catalyst, and H₂O as solvent. The photophysical properties (λ_Abs., λ_Flu.) of the synthesized compounds in CH₂Cl₂, MeCN, and MeOH have been measured. The emission spectra of the new compounds in the solid state are also reported.     

2-乙烯基噻吩-8-羟基喹啉锌的设计合成及光致发光特性研究

合成了2-[2-(5-溴代噻吩-2-基)-乙烯基]-8-羟基喹啉(1)和2-[2-(5'-溴代二噻吩-5-基)-乙烯基]-8-羟基喹啉(2)两个新化合物; 利用IR, UV, ¹H NMR, MS, 元素分析等确认其结构; 利用X射线单晶衍射仪测定了化合物1的晶体结构; 用MTT法评价了化合物1和2对鼠骨髓间质干细胞在不同浓度下的影响, 研究结果表明它们对鼠骨髓间质干细胞具有增殖作用. 化合物1和2与醋酸锌反应获得了其相应的锌配合物3和4, 光致发光显示: 它们的λ_max分别是597和620 nm.      

Reductive Coupling Reaction of Aryliminomethylferrocenes with Triethyl Orthoformate Induced by Low‐valent Titanium

Reductive coupling reaction of aryliminomethylferrocenes FcCH = NAr[(1, Ar=QHs (a), p‐ClC₆H₄ (b), p‐BrC₆H₄ (c), p‐CH₃C₆H₄ (d), m‐ClC₆H₄ (e)] with triethyl orthoformate (2) in Zn‐TiCl₄ system gave three kinds of products: 1, 3‐diaryl‐4, 5‐diferrocenyl imidazolidines (3), N, N‐disubstituted formamides (4), and 1, 2‐diferrocenyl ethylene (5). ¹H NMR spectra proved that all the compounds 3 obtained were dl‐isomers. All the new compounds 3 and 4 were characterized by elemental analysis, ¹H NMR, ¹³C NMR (for 3) and IR spectra. The molecular structure of 3c was determined by X‐ray diffraction.     

Synthesis and Antimicrobial Activity of Novel Iminophosphocin Derivatives

Iminophosphocins 8a – 8e and 9a – 9e were synthesized in four‐step reactions via Staudinger reaction. 3‐(Bromomethyl)‐1,2,3,4,5‐pentahydro‐3λ⁵‐naphtho[1,8‐f,g][1,5,3]diazaphosphocin‐3‐one ( 3 ) was prepared by reacting tris(bromomethyl)phosphineoxide ( 1 ) with 1,8‐diaminonaphthalene ( 2 ) in the presence of triethylamine (TEA) in dry tetrahydrofuran (THF), and treated with L‐valine methyl ester ( 4 ) and bis(2‐chloroethyl)amine ( 5 ) in the presence of TEA in dry THF to get 3‐methyl‐2‐[(3‐oxo‐1,2,3,4,5‐pentahydro‐3λ⁵‐naphtho[1,8‐f,g][1,5,3]diazaphosphocin‐3‐yl)methylamino]butanoate ( 6 ) and 3‐[di(2‐chloroethyl)aminomethyl]‐1,2,3,4,5‐pentahydro‐3λ⁵‐ naphtho[1,8‐f,g][1,5,3]diazaphosphocin‐3‐one ( 7 ). The compounds 6 and 7 were treated with trichlorosilane (SiCl₃H) in dry tetrahydrofuran (THF) to form the trivalent P(III) intermediates 8 and 9 , which were further treated with various alkyl azides in dry THF in 55–60°C to afford the title compounds 8a – 8e and 9a – 9e . Their structures were established by multi‐nuclear NMR and mass spectra. All the newly synthesized compounds were found to possess moderate anti‐microbial activity.     

Fluorescence Quenching Study on the Interaction of Some Schiff Base Complexes with Bovine Serum Albumin

The interaction of Schiff base ligand A and its three metal complexes [A‐Fe(II), A‐Cu(II), and A‐Zn(II)] with bovine serum albumin (BSA) was investigated using a tryptophan fluorescence quenching method. The Schiff base ligand A and its three metal complexes all showed quenching of BSA fluorescence in a Tris‐HCl buffer. Quenching constants were determined for quenching BSA by the Schiff base ligand A and its metal complexes in a Tris‐HCl buffer (pH=7.4) at different temperatures. The experimental results show that the dynamic quenching constant (K_SV) was increased with increasing temperature, whereas the association constant (K) was decreased with the increase of temperature. The thermodynamic parameters ΔH, ΔG and ΔS at different temperatures were calculated. The ionic strength of the Tris‐HCl buffer had a great influence on the wavelength of maximum emission of BSA. Under low ionic strength, the emission spectra of BSA influenced by A‐Zn(II) had a small blue shift. Compared to A‐Zn(II), the emission spectra of BSA in the presence of the Schiff base ligand A and A‐Cu(II) had no significant λ_em shift. At high ionic strength, the emission spectra of BSA upon addition of the Schiff base A, A‐Fe(II), and A‐Zn(II) all had a red shift, but the emission spectra of BSA had λ_em shift neither at low ionic strength, nor at high ionic strength in the presence of A‐Cu(II). Furthermore, the temperature did not affect the λ_em shift of BSA emission spectra.     

Diselenadiphosphetandiselenide und Triselenadiphospholandiselenide – Synthese und Charakterisierung mittels 31P‐ und 77Se‐Festkörper‐NMRSpektroskopie

Diselenadiphosphetane Diselenides and Triselenadiphospholane Diselenides – Synthesis and Characterization by ³¹P and ⁷⁷Se Solid‐State NMR Spectroscopy 1,3‐Diselena‐2,4‐diphosphetane‐2,4‐diselenides (RPSe₂)₂ with R = Me, Et, t‐Bu, Ph, 4‐Me₂NC₆H₄, 4‐MeOC₆H₄ have been synthesized by different methods. The insoluble compounds were investigated by ³¹P and ⁷⁷Se solid‐state NMR and the purity of the compounds has been checked by their CP MAS sideband NMR spectra. The structure of the investigated compounds has been confirmed by the isotropic and anisotropic values of the chemical shifts and the ¹J_P–Se coupling constants. In addition, two new 1,2,4‐triselena‐3,5‐diphospholane‐3,5‐diselenides, (RPSe₂)₂Se (R = Me, Et), formed under similar synthesis conditions, were investigated. Their structure was derived from the ⁷⁷Se satellites of ³¹P solution spectra and from solid‐state spectra. For (t‐BuPSe₂)₂ the experimentally obtained principal values of phosphorus and selenium shielding tensors are compared with values from IGLO calculations (HF und SOS DFPT). The calculated orientations of the principal axes are discussed.     

Modified Riemschneider Reaction of 3‐Thiocyanatoquinolinediones

The Riemschneider reaction of 3‐thiocyanatoquinoline‐2,4(1H,3H)‐diones with conc. H₂SO₄ was investigated. Using different reaction conditions, 13 types of reaction products were isolated. Compounds bearing a Me, Et, or Bu group at C(3) afforded mainly [1,3]thiazolo[5,4‐c]quinoline‐2,4‐diones and 1,9b‐dihydro‐9b‐hydroxythiazolo[5,4‐c]quinoline‐2,4‐diones. In the case of the 3‐Bu derivatives of the starting compounds, C‐debutylation was also observed. If a Bn group is present at C(3), rapid C‐debenzylation of the starting thiocyanates occurred, yielding [1,3]oxathiolo[4,5‐c]quinoline‐2,4‐diones, and mixtures of mono‐, di‐, and trisulfides derived from 4‐hydroxy‐3‐sulfanylquinoline‐2‐ones. The reaction mechanism of all of the transformations is discussed. All new compounds were characterized by IR, ¹H‐ and ¹³C‐NMR, and EI and ESI mass spectra, and in some cases, ¹⁵N‐NMR spectra were also used to characterize new compounds.     

Covalent‐Bond Formation in the Course of the Inhibition of δ‐Chymotrypsin with trans‐Decalin‐Type Organophosphates: 31P‐NMR Evidence

Earlier investigations have shown that the irreversible inhibition of δ‐chymotrypsin with the axially substituted trans‐3‐(2,4‐dinitrophenoxy)‐2,4‐dioxa‐3λ⁵‐phosphabicyclo[4.4.0]decan‐3‐one (=2‐(2,4‐dinitrophenoxy)hexahydro‐4H‐1,3,2‐benzodioxaphosphorin 2‐oxide) proceeds under inversion of the configuration at the P‐atom. Since this assignment is based on the comparison of the respective chemical shifts with model compounds, the covalent nature of the binding interaction between enzyme and inhibitor was formulated in analogy. To prove this assumption, inhibition experiments were performed with the deuterated inhibitor (±)‐trans‐3‐(2,4‐dinitrophenoxy)‐2,4‐dioxa‐3λ⁵‐phospha(1,5,5‐²H₃)bicyclo[4.4.0]decan‐3‐one ((±)‐ 6a ). ³¹P{²H}‐NMR‐Spectroscopic monitoring of the reaction of stoichiometric amounts of the enzyme with (±)‐ 6a at pH 7.8 yielded the diastereoisomeric adducts 9 (−3.88 ppm) and 9′ (−3.96 ppm). Comparing the ³¹P chemical shifts of the corresponding deuterated covalent phosphoserine model compounds 8a/8a′ (−6.70 ppm, axial) and 8b/8b′ (−4.11/−4.13 ppm, equatorial) confirmed the inversion of the configuration at the P‐atom. ¹H‐Correlated ³¹P{²H}‐NMR spectra revealed a cross peak of the Ser¹⁹⁵‐H₂ (4.45 ppm) with the P‐atom of the inhibitor at −3.88/−3.96 ppm, thus establishing the covalent nature of the Ser¹⁹⁵−O−P bond.     

Protonierung des 1,1,3,3,5,5‐Hexakis(dimethylamino)λ5‐[1,3,5]triphosphinins. Cyclotrimethylentriphosphinsäure. NMR‐Daten,Kristallstrukturen und quantenchemische Rechnungen

Protonation of 1,1,3,3,5,5‐Hexakis(dimethylamino)‐λ⁵‐[1,3,5]triphosphinine. Cyclotrimethylenetriphosphinic Acid. NMR Data, Crystal Structures, and Quantum Chemical Calculations Preparation of 1,1,3,3,5,5‐hexakis(dimethylamino)‐1,2‐dihydro‐3λ⁵,5λ⁵‐[1,3,5]triphosphininium‐tetrafluoroborate ( 3 ) und 1,1,3,3,5,5‐hexakis(dimethylamino)‐λ⁵‐[1,3,5]triphosphinanetriium‐tris(tetrafluoroborate) ( 4 ) from 1,1,3,3,5,5‐hexakis(dimethylamino)‐1λ⁵,3λ⁵,5λ⁵‐triphosphinine 1 and HBF₄ · O(C₂H₅)₂ are described. The structures of 3 und 4 are elucidated by n. m. r. and X‐ray structural analyses. By hydrolysis of 4 with conc. hydrochloric acid 1,3,5‐trioxo‐1λ⁵,3λ⁵,5λ⁵‐[1,3,5]triphosphinane‐1,3,5‐triol (cyclotrimethylene‐triphosphinic acid) ( 8 ) is formed. Neutralisation with NaOH yields its sodium salt 9 . 8 and 9 are characterized by their n. m. r. spectra. Quantum chemical calculations have been investigated for the compounds 1 ′– 4 ′ and the trianion 9 . The systems 1 ′– 4 ′ are distinguished from 1 – 4 by the size of the ligands at phosphorus which is reduced from N(CH₃)₂ to NH₂, respectively. The aims of the calculations are to elucidate hybridisations and molecular structures, Lewis or resonance structures, electronic charge distributions and NMR chemical shifts.     

Zwitterionic Spirocyclic λ5Si‐Silicates with Two Bidentate Acetohydroximato(2–) or Benzohydroximato(2–) Ligands: Synthesis,Structure, and Dynamic Stereochemistry

The syntheses of the zwitterionic spirocyclic λ⁵Si‐silicates 7–14 are described. The chiral zwitterions contain a pentacoordinate (formally negatively charged) silicon atom and a tetracoordinate (formally positively charged) nitrogen atom, the ate and onium center being connected by an alkylene group. The zwitterions each contain two identical bidentate diolato(2–) ligands that formally derive from acetohydroximic acid or benzohydroximic acid. The stereochemistry and dynamic behavior of these compounds were investigated by experimental and theoretical methods. For this purpose, the zwitterionic λ⁵Si‐silicates 7–14 were studied by solution (¹H, ¹³C, ²⁹Si) and solid‐state (¹³C, ¹⁵N, and ²⁹Si CP/MAS) NMR experiments. In addition, compounds 7 , 8 , 10 , 11 , and 13 were structurally characterized by single‐crystal X‐ray diffraction. The dynamic behavior (intramolecular enantiomerization) of 7 and 13 in solution was studied by VT ¹H NMR experiments. These experimental studies were completed by ab initio investigations of the related anionic model species 15 . The chiral compounds 7–14 exist as (λ)‐ and (δ)‐enantiomers in the solid state and in solution. The trigonal‐bipyramidal structure of the respective Si‐coordination polyhedra, with the two carbon‐linked oxygen atoms in the axial sites, is the energetically most favorable one. The (λ)‐ and (δ)‐enantiomers of 7–14 are configurationally stable in solution on the NMR time scale ([D₆]DMSO, room temperature). They undergo an intramolecular (λ)/(δ)‐enantiomerization (twist‐type mechanism), with an activation free enthalpy of δG^{ = 72–73 kJ mol^–1 (experimentally established for 7 and 13 ; calculated energy barrier for the model species 15 : 66.0 kJ mol^–1).